Clinical Trial Update: Pharmacokinetics/Pharmacodynamics of NOX-H94 in the Human Endotoxemia Model [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic/pharmacodynamic study of NOX-H94 in a human endotoxemia model has completed. The results provide PK/PD data to inform potential developm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Disease

Drugs mentioned

• NOX-H94

Snippet

Sponsor: TME Pharma AG | Conditions: Anemia of Chronic Disease | Phase 1 | Status: COMPLETED